Literature DB >> 10797963

[Scabies complicated by acute glomerulonephritis in children: 114 cases observed in two years in a pediatric service in Dakar].

M T Dieng1, B Ndiaye, A M Ndiaye.   

Abstract

We performed a retrospective study during 2 years in order to determine the clinical and epidemilogic characteristics of 144 cases of scabiosis with acute glomerulo-nephritis in Dakar. The 144 cases of scabiosis complicated with glomerulo-nephritis represented 56.6% of the whole 205 cases of scabiosis observed in the same period. The most important part of the cases was observed between November and January. Usually children came from poor and numerous family. The scabios lesions were mostly generalised and the infection was recent. The main features of the kidney disease were: oedemas(93.2%), high blood pressure (89.1%) and haematuria(54.70%). Cardiac and neurological involvement were the main complications. The global mortality was very low(1 case). The evolution was good in 97% of the case with complete cure.

Entities:  

Mesh:

Year:  1998        PMID: 10797963

Source DB:  PubMed          Journal:  Dakar Med        ISSN: 0049-1101


  3 in total

1.  Ivermectin versus benzyl benzoate applied once or twice to treat human scabies in Dakar, Senegal: a randomized controlled trial.

Authors:  Fatimata Ly; Eric Caumes; Cheick Ahmet Tidiane Ndaw; Bassirou Ndiaye; Antoine Mahé
Journal:  Bull World Health Organ       Date:  2009-06       Impact factor: 9.408

2.  Mass scabies management in an orphanage of rural community: An experience.

Authors:  Sunil Agrawal; Atul Puthia; Atul Kotwal; Rina Tilak; Renuka Kunte; A S Kushwaha
Journal:  Med J Armed Forces India       Date:  2012-08-24

3.  Etiology of Kidney Diseases With Proteinuria in the Gambia/West Africa.

Authors:  Udo Vester; Augustin Fombah; Maite Hölscher; Danlami Garba; Mary Tapgun; Pamela Collier N'Jai; Philipp Mendy; Gibril Bass; Abdul K Muhammad; Suzanne T Anderson; Abdoulie Sanneh; Charles Onyeama; Udo Helmchen; Khalifa Bojang; Peter F Hoyer; Tumani Corrah
Journal:  Front Pediatr       Date:  2022-03-21       Impact factor: 3.418

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.